CLINICAL CASE OF RUSSIAN THROMBOLYTIC AGENT FORTELYZIN® USE IN PATIENTS WITH ACUTE CORONARY ARTERY DISEASE

CLINICAL CASE OF RUSSIAN THROMBOLYTIC AGENT FORTELYZIN® USE IN PATIENTS WITH ACUTE CORONARY ARTERY DISEASE

One of the three clinical examples of hospital thrombolysis using Russian thrombolytic agent recombinant protein comprising an amino acid sequence of staphylokinase is described. The trial was held in Chelyabinsk Regional Vascular Centre of specialized medical care for patients with acute coronary s...

Full description

Saved in:

Bibliographic Details
Main Authors:	K. A. Kireev, A. V. Krasnopeev, S. V. Utkina
Format:	Article
Language:	English
Published:	Столичная издательская компания 2015-09-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	thrombolytic therapy percutaneous coronary intervention acute myocardial infarction recombinant protein comprising an amino acid sequence of staphylokinase
Online Access:	https://www.rpcardio.online/jour/article/view/56
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

RESULTS OF HOSPITAL USE OF RECOMBINANT NON-IMMUNOGENIC STAPHYLOKINASE IN PATIENTS WITH ST-ELEVATED MYOCARDIAL INFARCTION
by: V. B. Kostogryz
Published: (2017-03-01)

THROMBOLYTIC THERAPY IN PATIENTS WITH MYOCARDIAL INFARCTION
by: G. P. Ishmurzin, et al.
Published: (2010-12-01)

THROMBOLYTIC THERAPY OF ACUTE MYOCARDIAL INFARCTION
by: D. P. Sementsov
Published: (2015-12-01)

CORONARY REPERFUSION IN ST ELEVATION MYOCARDIAL INFARCTION: PROBLEMS AND SOLUTIONS
by: V. A. Markov, et al.
Published: (2015-01-01)

Non-immunogenic staphylokinase — a thrombolytic agent in the treatment of massive pulmonary embolism: results of the FORPE clinical trial
by: A. I. Kirienko, et al.
Published: (2024-12-01)

COMPARATIVE RESULTS OF RECOMBINANT NON-IMMUNOGENIC STAPHYLOKINASE AND TENECTEPLASE USE IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION IN REAL CLINICAL PRACTICE
by: E. S. Mazur, et al.
Published: (2017-09-01)

Some Aspects of Prehospital Thrombolytic Therapy in the Perm Region
by: S. A. Naumov, et al.
Published: (2018-09-01)

Clinical case of the non-immunogenic recombinant staphylokinase usage in the treatment of massive pulmonary embolism in patient with genetically determined thrombophilia
by: G. D. Azizova, et al.
Published: (2025-04-01)

COMPLICATIONS OF THROMBOLYTIC THERAPY IN ACTUAL CLINICAL PRACTICE
by: A. F. Sharafutdinova, et al.
Published: (2014-07-01)

TO THE QUESTION OF EFFICACY AND SAFETY OF FORTELYZIN® THERAPY ON ACUTE CORONARY SYNDROME: TWO CLINICAL CASES
by: D. S. Yunevich, et al.
Published: (2018-03-01)

The Efficacy of Thrombolytic Therapy in Inferior Myocardial Infarction with Damage to the Right Ventricular
by: E. S. Mazur, et al.
Published: (2021-05-01)

Pharmacoinvasive strategy in the treatment of acute myocardial infarction: current state-of-the-art
by: A. S. Tereshchenko, et al.
Published: (2021-07-01)

Clinical features of the acute period of myocardial infarction with ST segment elevation in patients after reperfusion therapy
by: S. M. Kyselov, et al.
Published: (2020-10-01)

Clinical effectiveness of thrombolytic therapy with alteplase and double antiplatelet therapy in acute myocardial infarction
by: D. N. Kuznetsov, et al.
Published: (2011-12-01)

Prolonged Successful Cardiopulmonary Resuscitation with Thrombolysis in a Patient with Acute Coronary Syndrome
by: G. V. Klein, et al.
Published: (2019-01-01)

Long-Term Outcomes of Pharmacoinvasive Reperfusion Strategy Depending on the Choice of Thrombolytic Agent in ST-Segment Elevation Myocardial Infarction
by: A. V. Khripun, et al.
Published: (2019-05-01)

Investigating the Nurses and Doctors Attitudes' Regarding the Management of Acute Myocardial Infarction Patients Who Used the Thrombolytic Agents in Babylon Teaching Hospitals 2022
by: Hussein Abbas Salman Al-Ameri, et al.
Published: (2024-05-01)

Influence of thrombolytic therapy on the condition of matrix metalloproteinase and their inhibitors system in patients with Q-wave myocardial infarction
by: S. M. Kyselov
Published: (2014-08-01)

Selecting of statins optimum dosage regimen in patients with acute Q-wave myocardial infarction after thrombolytic therapy
by: V. D. Syvolap, et al.
Published: (2014-04-01)

Use of pharmacoinvasive approach to the treatment of patients with ST segment elevation acute coronary syndrome: state of the problem
by: S. R. Gilyarevskiy, et al.
Published: (2015-12-01)

Assessment of Nurse’s Knowledge Concerning nursing care of the patients receiving thrombolytic therapy with Acute Myocardial Infraction at Coronary Care Unit in Al-Diwaniya Teaching Hospital
by: Bahaa M. Skal, et al.
Published: (2021-06-01)

Pathogenesis and clinical significance of reperfusion arrhythmias in acute myocardial infarctio
by: V. E. Oleynikov, et al.
Published: (2024-10-01)

Low-molecular heparins in thrombolytic therapy of myocardial infarction patients
by: I. S. Yavelov
Published: (2009-12-01)

Successful treatment of cardiogenic shock by stenting of the left main coronary artery in acute myocardial infarction
by: Knežević Božidarka, et al.
Published: (2008-01-01)

Percutaneous transluminal coronary angioplasty in the right ventricle myocardial infarction treatment
by: Rafajlovski Saša I., et al.
Published: (2005-01-01)

Trimetazidine effects on red blood cell membrane lipids and necrosis area size in thrombolytic therapy of myocardial infarction
by: T. Yu. Rebrova, et al.
Published: (2009-04-01)

EFFECT OF GENDER DIFFERENCES ON THE EFFICACY AND SAFETY OF REPERFUSION THERAPY OF ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (DATA OF RETROSPECTIVE SINGLE-CENTER STUDY – HOSPITAL PERIOD)
by: D. B. Nemik, et al.
Published: (2016-06-01)

Pre-hospital management of acute coronary syndrome
by: S. N. Tereshchenko, et al.
Published: (2009-06-01)

CLINICAL CASE HISTORY OF EPTIFIBATIDE USE DURING CORONARY INTERVENTION IN PATIENT WITH CORONARY FAILURE
by: K. A. Kireev, et al.
Published: (2015-09-01)

Clinical characteristics and outcomes of acute coronary syndrome patients in a PCI-Limited setting: a prospective study from Bhutan
by: Chempay, et al.
Published: (2025-04-01)

CORONARY EMBOLISM WITH FRAGMENTED THROMBUS FROM THE LEFT VENTRICLE IN PATIENT WITH POSTINFARCTION ANEURYSM
by: Yu. F. Salakhova, et al.
Published: (2016-01-01)

Late opening of occluded coronary artery in myocardial infarction patients: is it always advisable?
by: S. V. Shalaev, et al.
Published: (2007-12-01)

Prospects for a pharmacoinvasive strategy in ST-elevation myocardial infarction in the Russian Federation
by: V. E. Oleynikov, et al.
Published: (2025-04-01)

TREATMENT OF THE ACUTE CORONARY SYNDROME WITH ST SEGMENT ELEVATION AT THE PRE-HOSPITAL CARE
by: S. N. Tereshchenko, et al.
Published: (2016-01-01)

Assessment of the allergenic and immunotoxic properties of the recombinant non-immunogenic staphylokinase in preclinical and clinical trials
by: S. S. Markin, et al.
Published: (2025-07-01)

INTERRELATION OF TRANSCUTANEOUS CORONARY INTERVENTIONS FOR ACUTE FORMS OF CORONARY HEART DISEASE AND MORTALITY PARAMETERS IN TYUMEN REGION INHABITANTS
by: V. A. Kuznetsov, et al.
Published: (2014-06-01)

REGIONAL ALGORITHM OF CARE IN ST ELEVATION MYOCARDIAL INFARCTION
by: A. Yu. Vafin, et al.
Published: (2016-03-01)

Eurasian clinical guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndrome (NSTE-ACS)
by: O. L. Barbarash, et al.
Published: (2021-11-01)

PRE-HOSPITAL THROMBOLYSIS IN KRASNOYARSK: RESULTS OF A RETROSPECTIVE COMPARATIVE STUDY
by: S. A. Skripkin, et al.
Published: (2016-01-01)

Gender peculiarities of clinical and instrumental indexes in patients with acute Q-wave myocardial infarction after primary coronary intervention
by: Yu. V. Savchenko, et al.
Published: (2021-10-01)